hemay005
Small moleculeexperimental
Clinical trial activity
17 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
10
Phase 2
7
Phase 3
2
Phase 4
0
Earliest trial started Dec 1, 2016 (NCT03007810)
Timeline
Indications
Mechanism of action
- Phosphodiesterase 4AINHIBITOR
PDE4A inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- hemay005
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06908642 | Phase 1 | Dec 25, 2024 | Hemay Pharmaceutical PTY. LTD. |
| NCT06610903 | Phase 1 | Oct 18, 2024 | Hemay Pharmaceutical PTY. LTD. |
| NCT06380153 | Phase 1 | May 7, 2024 | Hemay Pharmaceutical PTY. LTD. |
| NCT06376474 | Phase 1 | Apr 28, 2024 | Hemay Pharmaceutical PTY. LTD., Huazhong University of Science and Technology |
| NCT06145893 | Phase 3 | Nov 15, 2023 | Hemay Pharmaceutical PTY. LTD., Peking University |
| NCT05941247 | Phase 1 | Jul 17, 2023 | Hemay Pharmaceutical PTY. LTD., Scientia Clinical Research Limited Sydney |
| NCT05769946 | Phase 2 | Nov 24, 2022 | Hemay Pharmaceutical PTY. LTD. |
| NCT05486104 | Phase 2 | Sep 1, 2022 | Capital Medical University, Hemay Pharmaceutical PTY. LTD. |
| NCT05468645 | Phase 1 | Jul 25, 2022 | Hemay Pharmaceutical PTY. LTD. |
| NCT05407246 | Phase 2 | Jun 24, 2022 | Hemay Pharmaceutical PTY. LTD. |
| NCT04839328 | Phase 3 | May 13, 2021 | Hemay Pharmaceutical PTY. LTD. |
| NCT04837235 | Phase 1 | Apr 29, 2021 | Hemay Pharmaceutical PTY. LTD. |
| NCT04609397 | Phase 2 | Nov 30, 2020 | Hemay Pharmaceutical PTY. LTD., Peking University |
| NCT04102241 | Phase 2 | May 30, 2019 | Hemay Pharmaceutical PTY. LTD., Zhejiang University |
| NCT03577626 | Phase 1 | Oct 10, 2018 | Chinese Academy of Medical Sciences, Hemay Pharmaceutical PTY. LTD. |
| NCT03570346 | Phase 1 | Jul 10, 2018 | Chinese Academy of Medical Sciences, Hemay Pharmaceutical PTY. LTD. |
| NCT03007810 | Phase 1 | Dec 1, 2016 | Hemay Pharmaceutical PTY. LTD. |
Showing 17 of 17 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hemay Pharmaceutical PTY. LTD. | For profit | 17 | 17 | 3 | 2016 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 2 | 0 | 1 | 2018 |
| Peking University | Academic/Hospital | 2 | 0 | 2 | 2020 |
| Capital Medical University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Huazhong University of Science and Technology | Academic/Hospital | 1 | 0 | 1 | 2024 |
| Scientia Clinical Research Limited Sydney | For profit | 1 | 0 | 1 | 2023 |
| Zhejiang University | Academic/Hospital | 1 | 0 | 1 | 2019 |
7 organizations
Page 1 / 1